Skip to main content
Fig. 2 | Virology Journal

Fig. 2

From: Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccination

Fig. 2

PRNT50 antibody titres to SARS-CoV-2 Omicron subvariants BA.2.86 and JN.1 in BNT162b2 in individuals boosted by a BNT162b2 (WT + BA.4/5) bivalent vaccine (BBB + BIV) (N = 8). The PRNT50 titre to BA.2.86 and JN.1 in each individual is linked by a solid line. GMTs between the two groups were tested using Mann-Whitney U test. The horizontal dotted line at a titre 1:25.6 represents the 50% protective threshold against symptomatic infection as defined by Khoury et al. [8] (see text) and the shaded area represents the 95% confidence interval of this protective threshold

Back to article page

Virology Journal

ISSN: 1743-422X